- Current report filing (8-K)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

---

 

FORM 8-K

 

---

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)  November 13, 2008

 

WORLD HEART CORPORATION

(Exact name of registrant as specified in charter)

 

Canada		000-28882		52-2247240
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

7799 Pardee Lane, Oakland CA		94621
(Address of principal executive offices)		(Zip Code)

 

[phone]

Registrant’s telephone number, including area code

 

Not Applicable

(Former name or former address, if changed since last report)

 

---

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o                                     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                                     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                                     Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240.14d-2(b))

 

o                                     Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

 

Item 8.01    Other Events

 

On November 13, 2008, World Heart Corporation (“WorldHeart” or the “Company”) received a letter from The NASDAQ Stock Market (“NASDAQ”) stating that the Company has regained compliance with Marketplace Rule 4310(c)(4) (the “Minimum Bid Price Rule”) and has maintained a closing bid price of its ordinary shares at $1.00 per share or greater for at least 10 consecutive business days. This matter is now closed with the NASDAQ.

 

A copy of the press release is attached as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

The following exhibit is being furnished herewith:

 

Exhibit No.		Description of Exhibit.
99.1		Press release, dated November 18, 2008

 

2

---

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

 

Date: November 18, 2008
		WORLD HEART CORPORATION
	By:	/s/ David Pellone
	Name:	David Pellone
	Title:	Vice President, Finance and Chief Financial Officer

 

3

---